121 related articles for article (PubMed ID: 9273190)
1. [A combined radiochemotherapy trial for non-small cell lung cancers: initial results].
Livartowski A; Dubray B; Dierick A; Beuzeboc P; Pouillart P; Cosset JM
Cancer Radiother; 1997; 1(2):170-3. PubMed ID: 9273190
[TBL] [Abstract][Full Text] [Related]
2. Combined chemoradiation for locally advanced nonsmall cell lung cancer.
Dubray B; Livartowski A; Beuzeboc P; Pouillart P; Cosset JM
J Infus Chemother; 1995; 5(4):195-6. PubMed ID: 8934726
[TBL] [Abstract][Full Text] [Related]
3. [Induction chemotherapy followed by concomitant combined radiotherapy and chemotherapy in stage III non-small cell bronchial carcinoma].
Bouillet T; Morère JF; Mazeron JJ; Piperno-Neuman S; Boaziz C; Haddad E; Breau JL
Cancer Radiother; 1997; 1(2):121-31. PubMed ID: 9273182
[TBL] [Abstract][Full Text] [Related]
4. [Optimization of combined radiotherapy and chemotherapy in treatment of non-small cell lung carcinoma].
Bretel JJ; Arriagada R; Le Chevalier T; Baldeyrou P; Grunenwald D; Le Péchoux C; Pellae-Cosset B; Ruffié P
Cancer Radiother; 1997; 1(2):148-53. PubMed ID: 9273186
[TBL] [Abstract][Full Text] [Related]
5. Concurrent radiochemotherapy with vinorelbine plus cisplatin or carboplatin in patients with locally advanced non-small-cell lung cancer (NSCLC) and an increased risk of treatment complications. Preliminary results.
Semrau S; Bier A; Thierbach U; Virchow C; Ketterer P; Fietkau R
Strahlenther Onkol; 2003 Dec; 179(12):823-31. PubMed ID: 14652671
[TBL] [Abstract][Full Text] [Related]
6. A phase II trial of radiochemotherapy with daily carboplatin, after induction chemotherapy (carboplatin and etoposide), in locally advanced nonsmall-cell lung cancer: final analysis.
Bardet E; Rivière A; Charloux A; Spaeth D; Ducoloné A; Le Groumellec A; Pellae-Cosset B; Henry-Amar M; Douillard JY
Int J Radiat Oncol Biol Phys; 1997 Apr; 38(1):163-8. PubMed ID: 9212019
[TBL] [Abstract][Full Text] [Related]
7. A phase I study of daily carboplatin and simultaneous accelerated, hyperfractionated chest irradiation in patients with regionally inoperable non-small cell lung cancer.
Kelly K; Hazuka M; Pan Z; Murphy J; Caskey J; Leonard C; Bunn PA
Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):559-67. PubMed ID: 9486605
[TBL] [Abstract][Full Text] [Related]
8. [Concomitant radiochemotherapy in inoperable non-small cell lung cancer].
Hennequin C; Trédaniel J; Durdux C; Salemkour A; Zalcman G; Hirsch A; Housset M; Maylin C
Cancer Radiother; 1997; 1(2):143-7. PubMed ID: 9273185
[TBL] [Abstract][Full Text] [Related]
9. A prospective phase II study of induction carboplatin and vinorelbine followed by concomitant topotecan and accelerated radiotherapy (ART) in locally advanced non-small cell lung cancer (NSCLC).
Patel SH; Ajlouni M; Chapman R; Lu M; Movsas B; Kim JH
J Thorac Oncol; 2007 Sep; 2(9):831-7. PubMed ID: 17805061
[TBL] [Abstract][Full Text] [Related]
10. A phase II study of concurrent carboplatin and paclitaxel and thoracic radiotherapy for completely resected stage II and IIIA non-small cell lung cancer.
Feigenberg SJ; Hanlon AL; Langer C; Goldberg M; Nicolaou N; Millenson M; Coia LR; Lanciano R; Movsas B
J Thorac Oncol; 2007 Apr; 2(4):287-92. PubMed ID: 17409799
[TBL] [Abstract][Full Text] [Related]
11. Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in patients with unresectable, locally advanced non-small cell lung carcinoma: report of Fox Chase Cancer Center study 94-001.
Langer CJ; Movsas B; Hudes R; Schol J; Keenan E; Kilpatrick D; Yeung C; Curran W
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-89-S12-95. PubMed ID: 9331129
[TBL] [Abstract][Full Text] [Related]
12. Concurrent daily carboplatin and accelerated hyperfractionated thoracic radiotherapy in locally advanced nonsmall cell lung cancer.
Kunitoh H; Watanabe K; Nagatomo A; Okamoto H; Kimbara K
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(1):103-9. PubMed ID: 9054883
[TBL] [Abstract][Full Text] [Related]
13. [Concurrent split-course chemotherapy and radiotherapy for unresectable stage III non-small cell lung cancer: preliminary results of a Phase II study].
Benchalal M; Salze P; Bombaron P; Bourderont D; Neidhardt AC; Maitre AM; Pignol JP; Lambert J; Baumann J; Sizaret O; Newinger G; Noirclerc M; Sabountchi M; Zipper JM; Prevot G
Cancer Radiother; 1999; 3(6):453-60. PubMed ID: 10630157
[TBL] [Abstract][Full Text] [Related]
14. Phase I-II trial of concomitant continuous carboplatin (CBDCA) infusion and radiotherapy in advanced nonsmall cell lung cancer with evaluation for surgery: final report.
Trodella L; Cellini N; Picciocchi A; Marano P; Balducci M; Mantini G; Turriziani A; Corbo GM; Valente S; Valentini V; Pirronti T; Granone P; Dobelbower RR
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(1):93-101. PubMed ID: 9054882
[TBL] [Abstract][Full Text] [Related]
15. Alternated approach with local irradiation and combination chemotherapy including cisplatin or carboplatin plus epirubicin and etoposide in intermediate stage non-small cell lung cancer.
Comella P; Scoppa G; Daponte A; Musetta G; Anania C; Maiorino A; Curcio C; Casaretti R; Comella G
Cancer; 1994 Oct; 74(7):1874-81. PubMed ID: 8082093
[TBL] [Abstract][Full Text] [Related]
16. Weekly paclitaxel and cisplatin with concurrent radiotherapy in locally advanced non-small-cell lung cancer: a phase I study.
Frasci G; Comella P; Scoppa G; Guida C; Gravina A; Fiore F; Casaretti R; Daponte A; Parziale A; Comella G
J Clin Oncol; 1997 Apr; 15(4):1409-17. PubMed ID: 9193333
[TBL] [Abstract][Full Text] [Related]
17. Phase I study of induction chemotherapy and concomitant chemoradiotherapy with irinotecan, carboplatin, and paclitaxel for stage III non-small cell lung cancer.
Choong NW; Vokes EE; Haraf DJ; Tothy PK; Ferguson MK; Kasza K; Rudin CM; Hoffman PC; Krauss SA; Szeto L; Mauer AM
J Thorac Oncol; 2008 Jan; 3(1):59-67. PubMed ID: 18166842
[TBL] [Abstract][Full Text] [Related]
18. Daily low-dose cisplatin plus concurrent high-dose thoracic irradiation in locally advanced unresectable non-small-cell lung cancer: results of a phase II Southwest Oncology Group study.
Hazuka MB; Crowley JJ; Bunn PA; O'Rourke M; Braun TJ; Livingston RB
J Clin Oncol; 1994 Sep; 12(9):1814-20. PubMed ID: 8083705
[TBL] [Abstract][Full Text] [Related]
19. Induction therapy with carboplatin/paclitaxel followed by concurrent carboplatin/paclitaxel and dose-escalating conformal radiotherapy in the treatment of locally advanced, unresectable non-small cell lung cancer: preliminary report of a phase I trial.
Socinski MA; Clark JA; Halle J; Steagall A; Kaluzny B; Rosenman JG
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-117-S12-122. PubMed ID: 9331135
[TBL] [Abstract][Full Text] [Related]
20. A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor support for advanced malignancies of the chest.
Vokes EE; Haraf DJ; Drinkard LC; Hoffman PC; Ferguson MK; Vogelzang NJ; Watson S; Lane NJ; Golomb HM
Cancer Chemother Pharmacol; 1995; 35(4):304-12. PubMed ID: 7530173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]